Navigation Links
Ocular Therapeutix, Inc. Appoints Two New Board Members
Date:10/1/2009

WALTHAM, Mass., Oct. 1 /PRNewswire/ -- Ocular Therapeutix, Inc. announced today the expansion of its board of directors with the appointment of Mr. Daniel Myers and Mr. Bernard Haffey.

Mr. Myers is currently the President, CEO and co-founder of Alimera Sciences, Inc., a biopharmaceutical company that is developing and commercializing prescription ophthalmic pharmaceuticals. Under his leadership, Alimera has raised venture funding totaling approximately $90M. Myers has over 25 years of experience in the ophthalmic pharmaceutical industry in sales, marketing, and general management. "I am pleased to have the opportunity to contribute to the Ocular Therapeutix Board of Directors. The I-ZIP® Ocular Bandage has the potential to be of great benefit to patients in the future," said Myers.

Mr. Haffey was most recently President and CEO of NDO Surgical, a medical technology company dedicated to the development of innovative endoscopic technologies for gastrointestinal diseases. Prior to this position, he joined IntraLase Corp. as Vice President, Business Development. With over 10 years experience in medical technology, Haffey has a proven track record of successfully launching emerging medical technology and medical device companies. Additionally, he has successfully helped three of his former companies through acquisition including NDO Surgical and Intralase. "I am delighted to be joining the world-class team at Ocular Therapeutix and look forward to helping the company achieve world-class business results," said Haffey.

"We are extremely fortunate to add industry veterans such as Bernie and Dan to our board. While Bernie brings commercial leadership and expertise particularly in the refractive and corneal areas, Dan has deep expertise in ophthalmic pharmaceutical and drug delivery. Their addition to our team will be key as we move forward towards commercialization of the I-ZIP bandage in the US and as we build our drug
'/>"/>

SOURCE Ocular Therapeutix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
2. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface
3. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
4. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
5. VELOCITY Broadcasting Appoints Senior Director of Strategic Business Development
6. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
7. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
8. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
9. NovaRx Appoints Industry Veteran as President and COO
10. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
11. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Today, the world,s largest and fastest provider ... more transparent, the importance of websites continues to grow ... maxim of "innovation brings progress and changes thinking" will ... The company has long been recognised as an international ... and modern approach, while also repeatedly breaking new ground ...
(Date:6/2/2015)... June 2, 2015  University Hospitals (UH) ... Cleveland area to implant a new miniaturized, ... HF System is the first and only FDA-approved heart failure ... admissions when used by physicians to manage heart failure., ... that is implanted in the pulmonary artery (PA) during a ...
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/d8nj6b/europe ) has announced ... Growth, Trends And Forecasts (2014 - 2019)" report ... Fluoroscopy is expected to grow at a healthy CAGR ... to view the gastrointestinal tract, to direct the movement ... the urinary system, to open narrowed or blocked blood ...
Breaking Medicine Technology:UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3European Fluoroscopy Market Report 2014-2019 - Growth, Trends And Forecasts 2
... , EAST HANOVER, N.J. , June 3 ... III study of Afinitor® (everolimus) tablets plus best supportive care ... survival, or time without tumor growth, in patients with advanced ... I n A dvanced N euroendocrine ...
... Today, the U.S. Food and Drug Administration (FDA) released final ... a long-acting beta-agonist (LABA).  This follows the FDA communication on 18 ... changes. , , , ... http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) , , ...
Cached Medicine Technology:Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 2Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 3Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 4Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 5Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 6Pivotal Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint in Study of Patients With Advanced Pancreatic Neuroendocrine Tumors 7FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 2FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 3FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 4FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 5FDA Updates U.S. Product Labels for LABA-Containing Medications Including AstraZeneca's SYMBICORT 6
(Date:6/3/2015)... 03, 2015 Come on out in ... a 200-mile overnight relay beginning in Madison, Wisconsin on ... Saturday, June 13th. , For the 4th consecutive year, ... will run to raise money for the Brain Aneurysm ... members of the Neurosurgery staff from The University of ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Unfortunately, a majority ... it comes to providing comfort to the users throughout the ... brand or one from the local market, the makers generally ... and, in the process, often overlook comfort and health. To ... of shoe, the creative heads at Vay Technologies have come ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 evigilo, ... multi-channel solutions, has showcased its new branding by launching ... , "The new brand identity: the logo depicting ... red, to green, the tagline – To Know. To ... new path evigilo is charting. A global, borderless approach ...
(Date:6/2/2015)... June 02, 2015 Allred Dental, a dental ... for the months June-September, 2015 along with a $100 off ... limited time only. , “Sometimes wisdom teeth can be impacted, ... jawbone. They can also only partially break through the gum, ... recovery is easier in young people, as they do not ...
(Date:6/2/2015)... Pleasant Prairie, WI (PRWEB) June 03, 2015 ... suited for regulated industries such as government, finance and ... any organization that wants reliable access control to enhance ... smart card keyboard requires the secondary authentication of a ... In addition to the smart-chipset card reader, the ...
Breaking Medicine News(10 mins):Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:$100 Off Coupon for Wisdom Teeth Extractions Offered at Allred Dental 2Health News:Introducing the New CHERRY JK-A0100EU Keyboard with Integrated Smart Card Reader for Access Control Security 2
... care , , WEDNESDAY, Nov. 5 (HealthDay News) -- Scientists ... of individuals, an Asian man and an African man, ... , The analysis of the DNA of the two ... care designed for each person,s genetic makeup is close ...
... AUGUSTA, Ga. The Medical College of Georgia announced ... Explorations grant from the Bill & Melinda Gates Foundation. ... research project conducted by Dr. Pandelakis A. Koni titled ... Dr. Koni,s project is one of 104 grants recently ...
... Examination Management,Services, Inc. (EMSI), a leading provider ... record retrieval services, announced today,that it has ... of sales for,Healthcare Services. In this role, ... and strategic partners to increase sales and ...
... 5 One of Fayette,County,s largest employers will expand ... of an $8.4 million, 20-year investment by the commonwealth., ... year through the,Fayette County Redevelopment Authority, on behalf of ... The funds will be used to jump start the ...
... Systems, Inc,(MPS) has signed a contract with Meadowview ... first facility in the state. The company is,now ... Pennsylvania,Maryland, Delaware, and West Virginia., Traci Henderson, ... than others and offered a connection to the,pharmacy ...
... for Corporate Support in Fighting Childhood Cancer and ... This year you can wear your,Halloween costume twice and ... with cancer who need help in paying medical bills ... out in their,favorite super hero costumes at this year,s ...
Cached Medicine News:Health News:Two More Human Genomes Mapped 2Health News:MCG receives $100,000 Grand Challenges Explorations grant for innovative global health research 2Health News:Groseth Rejoins EMSI to Lead Healthcare Services Sales 2Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Millennium Pharmacy Systems Expands into West Virginia 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 3
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
... Series Spectrophotometer is truly ... UV-VIS instrumentation. The latest ... into a radically new ... and performance unprecedented in ...
... the user to quickly and accurately count bacteria ... counting or manual counting. An optional 1.5X auxiliary ... to 3.0X. The adjustable focusing rod allows the ... The lens also rotates a full 360 for ...
The Accucount 2000 is designed to automatically count microscopic objects in a field displaying totals on a highly visible digital readout....
Medicine Products: